Quick Answer
ORTHOPEDIATRICS CORP reported Earnings Per Share Diluted of $1.69 (loss) per share for the year ending 2025.
- ORTHOPEDIATRICS CORP showed a decrease of -3.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from ORTHOPEDIATRICS CORP's annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $0.30 (loss) per share | Q2 2020: $0.54 (loss) per share | Q3 2020: $0.24 (loss) per share | Q4 2020: $0.73 (loss) per share | Q1 2021: $0.54 (loss) per share | Q2 2021: $0.19 (loss) per share | Q3 2021: $0.11 (loss) per share | Q4 2021: $0.00 per share | Q1 2022: $0.47 (loss) per share | Q2 2022: $0.02 (loss) per share | Q3 2022: $0.87 per share | Q1 2023: $0.30 (loss) per share | Q2 2023: $0.13 (loss) per share | Q3 2023: $0.20 (loss) per share | Q1 2024: $0.34 (loss) per share | Q2 2024: $0.26 (loss) per share | Q3 2024: $0.34 (loss) per share | Q1 2025: $0.46 (loss) per share | Q2 2025: $0.30 (loss) per share | Q3 2025: $0.50 (loss) per share.
- Over the full 7 years of available data (2019 to 2025), ORTHOPEDIATRICS CORP's Earnings Per Share Diluted has declined by 79.8%.
- Historical annual values: Fiscal year 2025: $1.69 (loss) per share | Fiscal year 2024: $1.64 (loss) per share | Fiscal year 2023: $0.92 (loss) per share | Fiscal year 2022: $0.06 per share | Fiscal year 2021: $0.84 (loss) per share | Fiscal year 2020: $1.82 (loss) per share | Fiscal year 2019: $0.94 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: